Page 22 - MemoriaCIBER-2018ENG

22
• Presentation of two business projects (of the • CIBERER and CIBERES) for the “Mind the
gap” forum of the Fundación Botín, reaching
Phase II with both of these.
• Obtaining a project at the Caixa Impulse 2018
call (CIBERER). •
• The continuing support for our spin-off
(Epidisease S.L.) has also continued in both
the application for proposals for projects and
of presentation to investors. •
• Proposals have also been submitted
at the Farma-Biotech Programme of Farmaindustria; the Caixaimpulse call and several open innovation programmes, such as that of the Fundación Kaertor.
• The CIBERER area has arranged symposia for cooperation with industry, an important one of which was “Public/Private initiative for Advanced Therapies in Rare Diseases” organised at the ISCIII on 28 May 2018.
• Along with the Plataforma de Malalties Minoritàries the CIBERER also arranged two new editions of the symposia on designation and development of orphan drugs, on 20 September at La Fe Hospital in Valencia and on 22 November 2018 at the Virgen del Rocío Hospital in Seville. The process of orphan drugs was explained at these events, from the preparation for obtaining this designation until these reach the patient.
In the CIBERES area support for the HIPARCO has gone on. A new financing agreement was negotiated by the Fundación la Caixa (finally signed by the IRB Lleida) and other calls were applied for (MthG, FIPSE, AGAUR, etc.)
On 8 November 2018, the CIBER- BBN area arranged the 1 Forum for Emergence of
new projects and “Tech transfer” along with Genesis Biomed at Barcelona’s Parc Científic.
In the CIBER-BBN area seven transfer projects were implemented in 2018 with the financial backing of seven companies. Six of these endeavours were got under way in 2018
and the seventh continued with the process previously started. A new call for this type of projects was issued, but none was awarded.
• Also, at CIBER-BBN, the first call for valorisation projects was made in December 2018. 8 project proposals were submitted and 6 were financed. These projects have the main aim of helping to increase the
TRL (Technology Readiness Level, the technology’s level of maturity) of their technologies in a step forward towards their exploitation and marketing (minimum TRL=3).
CIBER | ANNUAL REPORT 2018